Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis

Study Site 650, Vienna

Study Site 648, Linz

Study Site 649, Graz

Study Site 607, Berlin

Study Site 641, Berlin

Study Site 640, Potsdam

Study Site 620, Mahlow

Study Site 642, Buxtehude

Study Site 639, Hamburg

Study Site 600, Bielefeld

Study Site 617, Bochum

Study Site 601, Münster

Study Site 623, Bad Bentheim

Study Site 618, Osnabrück

Study Site 608, Bonn

Study Site 614, Mainz

Study Site 615, Selters

Study Site 602, Frankfurt am Main

Study Site 605, Heidelberg

Study Site 643, Stuttgart

Study Site 621, Erlangen

Study Site 606, Dresden

Study Site 611, Leipzig

Study Site 636, Bydgoszcz

Study Site 628, Iwonicz-Zdrój

Study Site 633, Krakow

Study Site 624, Krakow

Study Site 635, Krakow

Study Site 629, Lodz

Study Site 631, Olsztyn

Study Site 625, Osielsko

Study Site 645, Poznan

Study Site 644, Poznan

Study Site 634, Rzeszów

Study Site 638, Szczecin

Study Site 632, Torun

Study Site 627, Warsaw

Study Site 637, Wroclaw

Study Site 630, Wroclaw

Study Site 647, Wroclaw